The deal will reduce tariffs on pharmaceutical exports from Europe to India to zero from 11% for almost all products. This will also reduce input costs for specialized raw material that Indian firms ...
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.
Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...
Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...
Q4 2025 Earnings Call January 27, 2026 1:00 PM ESTCompany ParticipantsDavid Burg - Executive VP & CFORodger Levenson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results